A Pilot Study for Blood Based Biomarkers for Patients with Lung Cancer Receiving Radiation Therapy
T
Tim Lautenschlaeger, MD
Primary Investigator
Overview
The purpose of this study is to collect blood and tissue samples from patients with lung cancer before, during and after radiation therapy in order to identify potential biomarkers that might help us in the future to develop a blood or urine test that can be used to predict cancer reoccurrence and radiation therapy side effects for each individual patient.
Description
The purpose of this study is to collect blood and tissue samples from patients with lung cancer before, during and after radiation therapy in order to identify potential biomarkers that might help us in the future to develop a blood or urine test that can be used to predict cancer reoccurrence and radiation therapy side effects for each individual patient.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
lung cancer
-
Age: Between 18 Years - 100 Years
-
Gender: All
Inclusion Criteria
Willingness to undergo phlebotomy for research blood samples
Diagnosis of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)
Additional Information:Willingness to undergo phlebotomy for research blood samples
Diagnosis of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)
Updated on
18 Apr 2024.
Study ID: 1606191988 (IUSCC-0580)